What is a stock summary page? Click here for an overview.
Business Description
SenzaGen AB
ISIN : SE0010219626
Compare
Compare
Traded in other countries / regions
SENZA.Sweden IPO Date
2017-09-21Description
SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 22.24 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.45 | |||||
| Beneish M-Score | -2.45 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 44.1 | |||||
| 3-Year EBITDA Growth Rate | 19.2 | |||||
| 3-Year EPS without NRI Growth Rate | 35.8 | |||||
| 3-Year FCF Growth Rate | 22.3 | |||||
| 3-Year Book Growth Rate | -13.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.62 | |||||
| 9-Day RSI | 35.09 | |||||
| 14-Day RSI | 33.58 | |||||
| 3-1 Month Momentum % | -23.91 | |||||
| 6-1 Month Momentum % | -31.37 | |||||
| 12-1 Month Momentum % | -13.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.66 | |||||
| Quick Ratio | 4.38 | |||||
| Cash Ratio | 2.96 | |||||
| Days Inventory | 98.41 | |||||
| Days Sales Outstanding | 63.57 | |||||
| Days Payable | 72.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7 | |||||
| Shareholder Yield % | -31.2 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.89 | |||||
| Operating Margin % | -18.41 | |||||
| Net Margin % | -30.94 | |||||
| FCF Margin % | -24.07 | |||||
| ROE % | -22.25 | |||||
| ROA % | -16.88 | |||||
| ROIC % | -14.42 | |||||
| 3-Year ROIIC % | -849.03 | |||||
| ROC (Joel Greenblatt) % | -576.86 | |||||
| ROCE % | -18.06 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 14.8 | |||||
| PS Ratio | 2.05 | |||||
| PB Ratio | 1.48 | |||||
| Price-to-Tangible-Book | 3.31 | |||||
| EV-to-EBIT | -5.72 | |||||
| EV-to-Forward-EBIT | 154.97 | |||||
| EV-to-EBITDA | -5.72 | |||||
| EV-to-Forward-EBITDA | 14.09 | |||||
| EV-to-Revenue | 1.58 | |||||
| EV-to-Forward-Revenue | 1.73 | |||||
| EV-to-FCF | -6.16 | |||||
| Price-to-GF-Value | 0.32 | |||||
| Price-to-Net-Current-Asset-Value | 3.47 | |||||
| Price-to-Net-Cash | 8.92 | |||||
| Earnings Yield (Greenblatt) % | -17.47 | |||||
| FCF Yield % | -10.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SenzaGen AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 57.695 | ||
| EPS (TTM) (kr) | -0.67 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.38 | ||
| 3-Year Sortino Ratio | -0.54 | ||
| Volatility % | 42.58 | ||
| 14-Day RSI | 33.58 | ||
| 14-Day ATR (kr) | 0.306966 | ||
| 20-Day SMA (kr) | 4.8405 | ||
| 12-1 Month Momentum % | -13.65 | ||
| 52-Week Range (kr) | 3.86 - 9.8 | ||
| Shares Outstanding (Mil) | 29.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SenzaGen AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SenzaGen AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
SenzaGen AB Frequently Asked Questions
What is SenzaGen AB(OSTO:SENZA)'s stock price today?
The current price of OSTO:SENZA is kr4.37. The 52 week high of OSTO:SENZA is kr9.80 and 52 week low is kr3.86.
When is next earnings date of SenzaGen AB(OSTO:SENZA)?
The next earnings date of SenzaGen AB(OSTO:SENZA) is 2025-05-14.
Does SenzaGen AB(OSTO:SENZA) pay dividends? If so, how much?
SenzaGen AB(OSTO:SENZA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers